MedTrace Logo

Surveillance of Suicide Ideation in Adolescents (VISIA)

NCT06341634 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 339

Last updated 2025-03-13

No results posted yet for this study

Summary

The goal of this observational study is to validate an AI algorithm's capability to differentiate the population with suicidal ideation from a control population using various multimodal variables, including voice analysis, facial emotions, natural language, and proteomics data.

The primary research question it aims to answer is:

Is it possible to identify suicidal ideation and suicide risk in adolescents early and non-intrusively using multimodal data analysis through digital instruments equipped with artificial intelligence?

Participants in this study will be asked to:

Complete psychometric instruments to establish a gold standard for detecting suicide risk and suicidal ideation.

Provide voice recordings, facial emotion data, and linguistic content in natural and specific contexts.

Participate in salivary proteomics data collection.

This study compares three distinct groups:

Ideation: Adolescent patients with current suicidal ideation. Clinical Population: Psychological or psychiatric patients of the same age and gender without suicidal ideation.

General Population: Adolescents without known psychological or psychiatric pathology of the same age and gender, without suicidal ideation.

Researchers will compare these groups to determine if the AI algorithm is effective in differentiating individuals with suicidal ideation (Group 1) from both a clinical control group (Group 2) and a general population control group (Group 3) using the collected multimodal data. The study aims to assess the algorithm's ability to identify early signs of suicide risk in these distinct participant populations.

Conditions

  • Suicide
  • Distress, Emotional
  • Adolescent Behavior
  • Healthy

Sponsors & Collaborators

  • University of Vigo

    collaborator OTHER

  • Complejo Hospitalario Universitario de Vigo

    collaborator OTHER

  • Complexo Hospitalario de Ourense

    collaborator OTHER

  • Fundacin Biomedica Galicia Sur

    collaborator OTHER

  • Servicio Gallego de Salud

    lead OTHER_GOV

Principal Investigators

  • Alejandro García Caballero · University Hospital Complex of Ourense

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-06
Primary Completion
2025-06-30
Completion
2025-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06341634 on ClinicalTrials.gov